Key result
The novel RYR2 p.R176L variant was associated with an arrhythmic event rate of 2.89 per 1000 person-years across 38 carriers, demonstrating substantial phenotypic variability and low penetrance.
Why the study?
To describe a novel RYR2 variant associated with cardiac arrest in a mother and daughter and evaluate its clinical and genetic profile across a four-generation family.
Observational (n=108)
The identification of a novel RYR2 variant with low penetrance and substantial phenotypic variability highlights the importance of extending cascade screening beyond first-degree relatives in CPVT.
Supports extending cascade screening beyond first-degree relatives in CPVT; leaves open prospective validation of variant-specific risks.
BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited arrhythmia syndrome characterized by adrenergically driven ventricular arrhythmia predominantly caused by pathogenic variants in the cardiac ryanodine receptor (RyR2). We describe a novel variant associated with cardiac arrest in a mother and daughter. METHODS: Initial sequencing of the RYR2 gene identified a novel variant (c.527G > T, p.R176L) in the index case (the mother), and her daughter. Structural analysis demonstrated the variant was located within the N-terminal domain of RyR2, likely leading to a gain-of-function effect facilitating enhanced calcium ion release. Four generation cascade genetic and clinical screening was carried out. RESULTS: Thirty-eight p.R176L variant carriers were identified of 94 family members with genetic testing, and 108 family members had clinical evaluations. Twelve carriers were symptomatic with previous syncope and 2 additional survivors of cardiac arrest were identified. Thirty-two had clinical features suggestive of CPVT. Of 52 noncarriers, 11 had experienced previous syncope with none exhibiting any clinical features of CPVT. A documented arrhythmic event rate of 2.89/1000 person-years across all carriers was calculated. CONCLUSION: The substantial variability in phenotype and the lower than previously reported penetrance is illustrative of the importance of exploring family variants beyond first-degree relatives.
No takes yet. Share an insight, caveat, or question.
Tung et al. (2020) conducted an observational in Catecholaminergic polymorphic ventricular tachycardia (CPVT) (n=108). RYR2 p.R176L variant vs. Noncarriers was evaluated on Documented arrhythmic event rate. The novel RYR2 p.R176L variant was associated with an arrhythmic event rate of 2.89 per 1000 person-years across 38 carriers, demonstrating substantial phenotypic variability and low penetrance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: